Clinical Trial Update: Radiolabeled TSPO Targeted Molecular Probe in Glioma

View source ↗

Summary

A study evaluating a radiolabeled TSPO-targeted molecular probe for imaging glioma has been listed. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Radiolabeled TSPO Targeted Molecular Probe

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Glioma (Any Grade) in the Brain | Status: NOT_YET_RECRUITING